US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
Contrast injector systems are medical devices that use contrast media to enhance the visibility of complex body structures such as body fluids, tissues, arteries, and veins. The diagnosis is conducted with the help of many imaging procedures such as computed tomography (CT), magnetic resonance imaging (MRI), and angiography. The rise in geriatric population coupled with rapid rise in chronic diseases as well as the demand for early and minimal-invasive diagnosis are the key factors that drive the growth of the contrast injector systems market. However, the high cost of contrast injector systems and the risks associated with the use of contrast media in the injector system is projected to impede the market growth. Moreover, the increase in healthcare expenditure and the emergence of complex diseases in emerging economies are expected to create lucrative opportunities for key market players. The global Contrast Injector Systems market is valued at 620 million US$ in 2018 is expected to reach 1140 million US$ by the end of 2025, growing at a CAGR of 7.9% during 2019-2025. This report focuses on Contrast Injector Systems volume and value at global level, regional level and company level. From a global perspective, this report represents overall Contrast Injector Systems market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: Bracco Bayer AG Guerbet Group Medtron AG Ulrich GmbH & Co. KG GE Healthcare Shenzhen Seacrown Electromechanical Nemoto Kyorindo Sino Medical- Device Technology Vivid Imaging Network Imaging Systems IRadimed Corporation Covidien Agito Medical Merit Medical Systems Segment by Regions North America Europe China Japan Segment by Type Injector Systems Consumables Accessories Segment by Application Diagnostics Centers Clinics Hospitals Others
Table of Contents Executive Summary 1 Contrast Injector Systems Market Overview 1.1 Product Overview and Scope of Contrast Injector Systems 1.2 Contrast Injector Systems Segment by Type 1.2.1 Global Contrast Injector Systems Production Growth Rate Comparison by Type (2014-2025) 1.2.2 Injector Systems 1.2.3 Consumables 1.2.4 Accessories 1.3 Contrast Injector Systems Segment by Application 1.3.1 Contrast Injector Systems Consumption Comparison by Application (2014-2025) 1.3.2 Diagnostics Centers 1.3.3 Clinics 1.3.4 Hospitals 1.3.5 Others 1.4 Global Contrast Injector Systems Market by Region 1.4.1 Global Contrast Injector Systems Market Size Region 1.4.2 North America Status and Prospect (2014-2025) 1.4.3 Europe Status and Prospect (2014-2025) 1.4.4 China Status and Prospect (2014-2025) 1.4.5 Japan Status and Prospect (2014-2025) 1.5 Global Contrast Injector Systems Market Size 1.5.1 Global Contrast Injector Systems Revenue (2014-2025) 1.5.2 Global Contrast Injector Systems Production (2014-2025) 2 Global Contrast Injector Systems Market Competition by Manufacturers 2.1 Global Contrast Injector Systems Production Market Share by Manufacturers (2014-2019) 2.2 Global Contrast Injector Systems Revenue Share by Manufacturers (2014-2019) 2.3 Global Contrast Injector Systems Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Contrast Injector Systems Production Sites, Area Served, Product Types 2.5 Contrast Injector Systems Market Competitive Situation and Trends 2.5.1 Contrast Injector Systems Market Concentration Rate 2.5.2 Contrast Injector Systems Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Contrast Injector Systems Production Market Share by Regions 3.1 Global Contrast Injector Systems Production Market Share by Regions 3.2 Global Contrast Injector Systems Revenue Market Share by Regions (2014-2019) 3.3 Global Contrast Injector Systems Production, Revenue, Price and Gross Margin (2014-2019) 3.4 North America Contrast Injector Systems Production 3.4.1 North America Contrast ... | read more...